Found: 90
Select item for more details and to access through your institution.
An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03620-8
- By:
- Publication type:
- Article
The changes of estrogen receptor‐β variants expression in breast carcinogenesis: Decrease of estrogen receptor‐β2 expression is the key event in breast cancer development.
- Published in:
- Journal of Surgical Oncology, 2006, v. 93, n. 6, p. 504, doi. 10.1002/jso.20336
- By:
- Publication type:
- Article
Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells.
- Published in:
- Apoptosis, 2016, v. 21, n. 3, p. 351, doi. 10.1007/s10495-015-1208-z
- By:
- Publication type:
- Article
S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 392, doi. 10.1186/1471-2407-12-392
- By:
- Publication type:
- Article
Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients.
- Published in:
- BMC Cancer, 2008, v. 8, p. 1, doi. 10.1186/1471-2407-8-8
- By:
- Publication type:
- Article
ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 61, doi. 10.1038/sj.cgt.7700769
- By:
- Publication type:
- Article
Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 9, p. 725, doi. 10.1038/sj.cgt.7700494
- By:
- Publication type:
- Article
Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients.
- Published in:
- Oncology, 2011, v. 79, n. 3/4, p. 293, doi. 10.1159/000323333
- By:
- Publication type:
- Article
Phase II Study of Transarterial Holmium-166-Chitosan Complex Treatment in Patients with a Single, Large Hepatocellular Carcinoma.
- Published in:
- Oncology, 2009, v. 76, n. 1, p. 1, doi. 10.1159/000173735
- By:
- Publication type:
- Article
Relationship between p53 Overexpression and Gastric Cancer Progression.
- Published in:
- Oncology, 1997, v. 54, n. 2, p. 166, doi. 10.1159/000227682
- By:
- Publication type:
- Article
Overexpression of c-ErbB-2 Protein in Gastric Cancer by Immunohistochemical Stain.
- Published in:
- Oncology, 1996, v. 53, n. 3, p. 192, doi. 10.1159/000227559
- By:
- Publication type:
- Article
Perioperative Blood Transfusions and Prognosis in Patients with Curatively Resected Locally Advanced Gastric Cancer.
- Published in:
- Oncology, 1995, v. 52, n. 2, p. 170, doi. 10.1159/000227452
- By:
- Publication type:
- Article
Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 2, p. 264, doi. 10.1038/mt.2009.205
- By:
- Publication type:
- Article
Corrigendum to “Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL”.
- Published in:
- 2010
- By:
- Publication type:
- Correction notice
Novel Cancer Antiangiotherapy Using the VEGF Promoter-targeted Artificial Zinc-finger Protein and Oncolytic Adenovirus.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 6, p. 1033, doi. 10.1038/mt.2008.63
- By:
- Publication type:
- Article
VEGF-specific Short Hairpin RNA–expressing Oncolytic Adenovirus Elicits Potent Inhibition of Angiogenesis and Tumor Growth.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 2, p. 295, doi. 10.1038/sj.mt.6300023
- By:
- Publication type:
- Article
140. Enhanced Cell Killing Effect of E1 Modified Adenoviruses Expressing HSV-TK Suicide Gene.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S56, doi. 10.1016/j.ymthe.2006.08.161
- By:
- Publication type:
- Article
149. Coxsackie and Adenovirus Receptor Binding Ablation Reduces Adenovirus Liver Tropism and Toxicity.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S58, doi. 10.1016/j.ymthe.2006.08.170
- By:
- Publication type:
- Article
840. Markedly Enhanced Cytolysis by E1B-19kD-Deleted Oncolytic Adenovirus in Combination with Cisplatin.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S324, doi. 10.1016/j.ymthe.2006.08.926
- By:
- Publication type:
- Article
841. Anti-Tumor Effect of Tumor Specific Replicating Adenovirus Expressing IL-12 and IL-18.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S325, doi. 10.1016/j.ymthe.2006.08.927
- By:
- Publication type:
- Article
846. Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7.1 in an Immuneocompetenet Mouse Model.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S326, doi. 10.1016/j.ymthe.2006.08.932
- By:
- Publication type:
- Article
849. E1A- and E1B-Double Mutant Replicating Adenovirus Elicits Enhanced Oncolytic and Anti- Tumor Effects.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S327, doi. 10.1016/j.ymthe.2006.08.935
- By:
- Publication type:
- Article
850. Concurrent Delivery of GM-CSF and B7-1 Using an Oncolytic Adenovirus Elicits Potent Anti- Tumor Effect on the Growth Established B16-F10 Tumor Model.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S327, doi. 10.1016/j.ymthe.2006.08.936
- By:
- Publication type:
- Article
1019. Enhanced Therapeutic Effects of Recombinant Adenovirus Ad-AFPΔ19, Selectively Replicating in α-Fetoprotein-Producing Human Liver Cancer Cells
- Published in:
- 2005
- By:
- Publication type:
- Abstract
702. Concurrent Delivery of GM-CSF and B7-1 Using an Oncolytic Adenovirus Elicits Potent Anti-Tumor Effect on the Growth Established B16-F10 Tumor Model
- Published in:
- 2005
- By:
- Publication type:
- Abstract
551. Enhanced Cell Killing Effect of E1 Modified Adenoviruses Expressing HSV-TK Suicide Gene
- Published in:
- 2005
- By:
- Publication type:
- Abstract
541. Oncolytic Effects of Conditionally Replicating Adenoviruses (CRAds) with Mutations in E1A and E1B Regions
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Correlation of KIT and platelet-derived growth factor receptoramutations with gene activation and expression profiles in gastrointestinal stromal tumors.
- Published in:
- Oncogene, 2005, v. 24, n. 6, p. 1066, doi. 10.1038/sj.onc.1208358
- By:
- Publication type:
- Article
Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma.
- Published in:
- Head & Neck, 2016, v. 38, p. E1653, doi. 10.1002/hed.24294
- By:
- Publication type:
- Article
Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer.
- Published in:
- Head & Neck, 2010, v. 32, n. 2, p. 235, doi. 10.1002/hed.21177
- By:
- Publication type:
- Article
Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 14, p. 2090, doi. 10.1002/cncr.28711
- By:
- Publication type:
- Article
Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 3, p. 729, doi. 10.1002/cncr.26311
- By:
- Publication type:
- Article
Frequent Central Nervous System Failure After Clinical Benefit With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Korean Patients With Nonsmall-Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 5, p. 1336, doi. 10.1002/cncr.24877
- By:
- Publication type:
- Article
Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, p. 22, doi. 10.1111/j.1743-7563.2011.01399.x
- By:
- Publication type:
- Article
Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, p. 34, doi. 10.1111/j.1743-7563.2011.01400.x
- By:
- Publication type:
- Article
An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, p. 13, doi. 10.1111/j.1743-7563.2011.01398.x
- By:
- Publication type:
- Article
Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater.
- Published in:
- Tohoku Journal of Experimental Medicine, 2013, v. 230, n. 5, p. 21, doi. 10.1620/tjem.231.21
- By:
- Publication type:
- Article
Characterization of virus-mediated autoimmunity and the consequences for pathological process in patients with systemic lupus erythematosus.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 10, p. 2799, doi. 10.1007/s10067-023-06597-6
- By:
- Publication type:
- Article
Relaxin Expression From Tumor-Targeting Adenoviruses and Its Intratumoral Spread, Apoptosis Induction, and Efficacy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 20, p. 1482, doi. 10.1093/jnci/djj397
- By:
- Publication type:
- Article
Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-019-57218-9
- By:
- Publication type:
- Article
Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 300, doi. 10.4143/crt.2018.012
- By:
- Publication type:
- Article
Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 119, doi. 10.4143/crt.2018.019
- By:
- Publication type:
- Article
East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1177, doi. 10.4143/crt.2015.401
- By:
- Publication type:
- Article
Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 458, doi. 10.4143/crt.2015.135
- By:
- Publication type:
- Article
Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 45, doi. 10.4143/crt.2014.340
- By:
- Publication type:
- Article
Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3482, doi. 10.1111/1759-7714.13684
- By:
- Publication type:
- Article